dCas9-VPR-mediated transcriptional activation of functionally equivalent genes for gene therapy

[1]  Timothy J. Hohman,et al.  Protective genes and pathways in Alzheimer’s disease: moving towards precision interventions , 2021, Molecular Neurodegeneration.

[2]  D. Grimm,et al.  A universal protocol for isolating retinal ON bipolar cells across species via fluorescence-activated cell sorting , 2021, Molecular therapy. Methods & clinical development.

[3]  S. Ramalingam,et al.  Autosomal dominant retinitis pigmentosa with toxic gain of function: Mechanisms and therapeutics , 2020, European journal of ophthalmology.

[4]  J. Wijnholds,et al.  Novel Therapeutic Approaches for the Treatment of Retinal Degenerative Diseases: Focus on CRISPR/Cas-Based Gene Editing , 2020, Frontiers in Neuroscience.

[5]  C. Wahl-Schott,et al.  A gene therapy for inherited blindness using dCas9-VPR–mediated transcriptional activation , 2020, Science Advances.

[6]  H. Blum,et al.  Antisense Oligonucleotide- and CRISPR-Cas9-Mediated Rescue of mRNA Splicing for a Deep Intronic CLRN1 Mutation , 2020, Molecular therapy. Nucleic acids.

[7]  F. Zhang,et al.  CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors , 2020, Cell.

[8]  Claire M. Brown,et al.  Tutorial: guidance for quantitative confocal microscopy , 2020, Nature Protocols.

[9]  K. Anderson,et al.  Guidance for quantitative confocal microscopy , 2020, Nature Protocols.

[10]  R. Samulski,et al.  Engineering adeno-associated virus vectors for gene therapy , 2020, Nature Reviews Genetics.

[11]  Hendrik Weisser,et al.  Genome-wide investigation of gene-cancer associations for the prediction of novel therapeutic targets in oncology , 2020, Scientific Reports.

[12]  Huanbin Zhou,et al.  Targeted base editing in rice with CRISPR/ScCas9 system , 2020, Plant biotechnology journal.

[13]  David R. Liu,et al.  Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses , 2019, Nature Biomedical Engineering.

[14]  David R. Liu,et al.  Search-and-replace genome editing without double-strand breaks or donor DNA , 2019, Nature.

[15]  Terence R Flotte,et al.  Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here? , 2019, Annual review of virology.

[16]  Xia Li,et al.  Gain-of-Function Mutations: An Emerging Advantage for Cancer Biology. , 2019, Trends in biochemical sciences.

[17]  S. Prescott,et al.  A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene , 2019, Nature.

[18]  Peter C. DeWeirdt,et al.  Genetic screens in isogenic mammalian cell lines without single cell cloning , 2019, Nature Communications.

[19]  Carel B. Hoyng,et al.  Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina , 2019, Science Translational Medicine.

[20]  G. Gao,et al.  Adeno-associated virus vector as a platform for gene therapy delivery , 2019, Nature Reviews Drug Discovery.

[21]  Navneet Matharu,et al.  CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency , 2019, Science.

[22]  Silvio C. E. Tosatto,et al.  InterPro in 2019: improving coverage, classification and access to protein sequence annotations , 2018, Nucleic Acids Res..

[23]  P. Sieving,et al.  Accessory heterozygous mutations in cone photoreceptor CNGA3 exacerbate CNG channel–associated retinopathy , 2018, The Journal of clinical investigation.

[24]  M. Babu,et al.  Human Diseases from Gain-of-Function Mutations in Disordered Protein Regions , 2018, Cell.

[25]  Kang Zhang,et al.  In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  M. Mahfouz,et al.  CRISPR base editors: genome editing without double-stranded breaks , 2018, The Biochemical journal.

[27]  Maximilian Haeussler,et al.  CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens , 2018, Nucleic Acids Res..

[28]  Andreas Hierlemann,et al.  Smart Cell Culture Systems: Integration of Sensors and Actuators into Microphysiological Systems. , 2018, ACS chemical biology.

[29]  Michel Sadelain,et al.  Gene therapy comes of age , 2018, Science.

[30]  C. R. Esteban,et al.  In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation , 2017, Cell.

[31]  Nicole M. Gaudelli,et al.  Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage , 2017, Nature.

[32]  G. Aguirre,et al.  Variabilities in retinal function and structure in a canine model of cone-rod dystrophy associated with RPGRIP1 support multigenic etiology , 2017, Scientific Reports.

[33]  Livia S. Carvalho,et al.  Evaluating Efficiencies of Dual AAV Approaches for Retinal Targeting , 2017, Front. Neurosci..

[34]  David Cowburn,et al.  A promiscuous split intein with expanded protein engineering applications , 2017, Proceedings of the National Academy of Sciences.

[35]  C. Wahl-Schott,et al.  Peripherin-2 and Rom-1 have opposing effects on rod outer segment targeting of retinitis pigmentosa-linked peripherin-2 mutants , 2017, Scientific Reports.

[36]  J. Sahel,et al.  Insight into the mechanisms of enhanced retinal transduction by the engineered AAV2 capsid variant ‐7m8 , 2016, Biotechnology and bioengineering.

[37]  Dacheng Ma,et al.  Integration and exchange of split dCas9 domains for transcriptional controls in mammalian cells , 2016, Nature Communications.

[38]  T. Lancet.  Fit to serve , 2016, The Lancet.

[39]  Prashant Mali,et al.  A multifunctional AAV–CRISPR–Cas9 and its host response , 2016, Nature Methods.

[40]  Jean Bennett,et al.  Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial , 2016, The Lancet.

[41]  Predrag Radivojac,et al.  The Loss and Gain of Functional Amino Acid Residues Is a Common Mechanism Causing Human Inherited Disease , 2016, PLoS Comput. Biol..

[42]  C. Wahl-Schott,et al.  AAV Vectors for FRET-Based Analysis of Protein-Protein Interactions in Photoreceptor Outer Segments , 2016, Front. Neurosci..

[43]  David R. Liu,et al.  Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage , 2016, Nature.

[44]  E. Ayuso,et al.  Practical utilization of recombinant AAV vector reference standards: focus on vector genomes titration by free ITR qPCR , 2016, Molecular therapy. Methods & clinical development.

[45]  M. Biel,et al.  In Vivo Analysis of Disease-Associated Point Mutations Unveils Profound Differences in mRNA Splicing of Peripherin-2 in Rod and Cone Photoreceptors , 2016, PLoS genetics.

[46]  Eric J. Topol,et al.  Protective alleles and modifier variants in human health and disease , 2015, Nature Reviews Genetics.

[47]  Feng Zhang,et al.  Orthogonal gene knock out and activation with a catalytically active Cas9 nuclease , 2015, Nature Biotechnology.

[48]  G. Church,et al.  Cas9 gRNA engineering for genome editing, activation and repression , 2015, Nature Methods.

[49]  Wolfgang Wurst,et al.  Development of an intein-mediated split–Cas9 system for gene therapy , 2015, Nucleic acids research.

[50]  Yuta Nihongaki,et al.  Photoactivatable CRISPR-Cas9 for optogenetic genome editing , 2015, Nature Biotechnology.

[51]  S. E. Barker,et al.  Long-term effect of gene therapy on Leber's congenital amaurosis. , 2015, The New England journal of medicine.

[52]  Feng Zhang,et al.  A split-Cas9 architecture for inducible genome editing and transcription modulation , 2015, Nature Biotechnology.

[53]  Ron Weiss,et al.  Highly-efficient Cas9-mediated transcriptional programming , 2014, Nature Methods.

[54]  Alexandro E. Trevino,et al.  Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex , 2014, Nature.

[55]  L. Vandenberghe,et al.  Adeno-associated virus: fit to serve. , 2014, Current opinion in virology.

[56]  Max A. Horlbeck,et al.  Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation , 2014, Cell.

[57]  A. Wlodawer,et al.  Nature's recipe for splitting inteins. , 2014, Protein engineering, design & selection : PEDS.

[58]  Lief E. Fenno,et al.  Targeting cells with single vectors using multiple-feature Boolean logic , 2014, Nature Methods.

[59]  G. Church,et al.  CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering , 2013, Nature Biotechnology.

[60]  Christopher M. Vockley,et al.  RNA-guided gene activation by CRISPR-Cas9-based transcription factors , 2013, Nature Methods.

[61]  Morgan L. Maeder,et al.  CRISPR RNA-guided activation of endogenous human genes , 2013, Nature Methods.

[62]  Eli J. Fine,et al.  DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.

[63]  Luke A. Gilbert,et al.  CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.

[64]  T. Lamb,et al.  Evolution of phototransduction, vertebrate photoreceptors and retina , 2013, Progress in Retinal and Eye Research.

[65]  Deniz Dalkara,et al.  In Vivo–Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous , 2013, Science Translational Medicine.

[66]  B. A. French,et al.  Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery , 2013, Gene Therapy.

[67]  W. Hauswirth,et al.  A comprehensive review of retinal gene therapy. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[68]  R. Klein,et al.  The advent of AAV9 expands applications for brain and spinal cord gene delivery , 2012, Expert opinion on biological therapy.

[69]  V. Kefalov.  Rod and Cone Visual Pigments and Phototransduction through Pharmacological, Genetic, and Physiological Approaches* , 2011, The Journal of Biological Chemistry.

[70]  C. Rudolph,et al.  Adeno-associated virus serotype 9-mediated pulmonary transgene expression: effect of mouse strain, animal gender and lung inflammation , 2011, Gene Therapy.

[71]  M. Lock,et al.  Efficient serotype-dependent release of functional vector into the culture medium during adeno-associated virus manufacturing. , 2010, Human gene therapy.

[72]  Zhijian Wu,et al.  Effect of genome size on AAV vector packaging. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[73]  W. Hauswirth,et al.  High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[74]  James M. Wilson,et al.  Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[75]  Jürgen Cox,et al.  A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics , 2009, Nature Protocols.

[76]  H. Sweeney,et al.  Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. , 2008, Human gene therapy.

[77]  B. Wang,et al.  Protein trans-splicing as a means for viral vector-mediated in vivo gene therapy. , 2008, Human gene therapy.

[78]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[79]  K. Yau,et al.  Quantal noise from human red cone pigment , 2008, Nature Neuroscience.

[80]  Y. Kan,et al.  AAV serotype 1 mediates more efficient gene transfer to pig myocardium than AAV serotype 2 and plasmid , 2008, The journal of gene medicine.

[81]  K. Yau,et al.  Signaling Properties of a Short-Wave Cone Visual Pigment and Its Role in Phototransduction , 2007, The Journal of Neuroscience.

[82]  K. Nakatani,et al.  Physiological properties of rod photoreceptor cells in green-sensitive cone pigment knock-in mice. , 2007, The Journal of general physiology.

[83]  易美济.  科学仪器公司Thermo Fisher Scientific正式起航 , 2007 .

[84]  B. Hyman,et al.  Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain , 2006, Neuroscience.

[85]  L. Davies,et al.  Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways , 2006, Gene Therapy.

[86]  Amy E Palmer,et al.  Measuring calcium signaling using genetically targetable fluorescent indicators , 2006, Nature Protocols.

[87]  Amos Bairoch,et al.  ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins , 2006, Nucleic Acids Res..

[88]  O. Danos,et al.  Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice , 2006, Gene Therapy.

[89]  Lili Wang,et al.  Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[90]  Jianming Xu.  Preparation, culture, and immortalization of mouse embryonic fibroblasts. , 2005, Current protocols in molecular biology.

[91]  Bing Wang,et al.  Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart , 2005, Nature Biotechnology.

[92]  P. Reier,et al.  Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[93]  James M. Allen,et al.  Systemic delivery of genes to striated muscles using adeno-associated viral vectors , 2004, Nature Medicine.

[94]  M. Naash,et al.  Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. , 2004, Investigative ophthalmology & visual science.

[95]  John A. Stanturf,et al.  Where are we and how did we get here , 2003 .

[96]  G. Kobinger,et al.  Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. , 2001, Human molecular genetics.

[97]  James M. Wilson,et al.  Gene Therapy Vectors Based on Adeno-Associated Virus Type 1 , 1999, Journal of Virology.

[98]  Z. Hu,et al.  Protein trans-splicing by a split intein encoded in a split DnaE gene of Synechocystis sp. PCC6803. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[99]  T. Dryja,et al.  Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. , 1994, Science.

[100]  M. Al-Ubaidi,et al.  Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter , 1992, The Journal of cell biology.

[101]  P. Sharp,et al.  Recombinant retroviruses encoding simian virus 40 large T antigen and polyomavirus large and middle T antigens , 1986, Molecular and cellular biology.